Citigroup Inc. Has $38.34 Million Stock Position in Avantor, Inc. $AVTR

Citigroup Inc. lessened its stake in Avantor, Inc. (NYSE:AVTR) by 11.5% in the 3rd quarter, HoldingsChannel reports. The fund owned 3,072,134 shares of the company’s stock after selling 400,042 shares during the quarter. Citigroup Inc.’s holdings in Avantor were worth $38,340,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of AVTR. Dodge & Cox grew its stake in shares of Avantor by 17.1% during the second quarter. Dodge & Cox now owns 117,433,484 shares of the company’s stock valued at $1,580,655,000 after purchasing an additional 17,170,761 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Avantor by 1.8% during the 3rd quarter. Vanguard Group Inc. now owns 65,988,977 shares of the company’s stock worth $823,542,000 after buying an additional 1,135,279 shares in the last quarter. Greenhaven Associates Inc. bought a new position in Avantor in the 3rd quarter valued at $228,528,000. Invesco Ltd. increased its stake in shares of Avantor by 36.5% in the 2nd quarter. Invesco Ltd. now owns 15,933,860 shares of the company’s stock valued at $214,470,000 after buying an additional 4,264,449 shares during the period. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Avantor by 13.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,914,573 shares of the company’s stock valued at $214,210,000 after buying an additional 1,879,874 shares during the period. 95.08% of the stock is owned by institutional investors.

Insider Activity

In other Avantor news, Director Gregory L. Summe bought 100,000 shares of Avantor stock in a transaction on Thursday, February 12th. The shares were purchased at an average cost of $9.40 per share, for a total transaction of $940,000.00. Following the completion of the acquisition, the director owned 400,000 shares in the company, valued at approximately $3,760,000. The trade was a 33.33% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Sanjeev K. Mehra bought 350,000 shares of the firm’s stock in a transaction on Friday, December 5th. The stock was acquired at an average cost of $11.09 per share, with a total value of $3,881,500.00. Following the completion of the purchase, the director owned 350,000 shares of the company’s stock, valued at approximately $3,881,500. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders bought 500,000 shares of company stock valued at $5,279,500 in the last quarter. Company insiders own 1.20% of the company’s stock.

Avantor Price Performance

Avantor stock opened at $9.10 on Wednesday. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $6.21 billion, a P/E ratio of -11.67, a PEG ratio of 3.50 and a beta of 0.94. The business has a 50-day moving average of $11.10 and a 200-day moving average of $12.07. Avantor, Inc. has a 1 year low of $8.83 and a 1 year high of $18.02.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.01. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The business had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm earned $0.27 EPS. Avantor’s quarterly revenue was down 1.4% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, equities analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on AVTR. Jefferies Financial Group reaffirmed an “underperform” rating and set a $8.00 price target on shares of Avantor in a research note on Thursday, February 12th. Citigroup cut their target price on shares of Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research report on Thursday, February 12th. Wells Fargo & Company reduced their target price on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Bank of America downgraded shares of Avantor from a “buy” rating to a “neutral” rating and set a $13.00 price target for the company. in a research note on Monday, December 15th. Finally, Morgan Stanley set a $10.00 price objective on shares of Avantor in a report on Friday, February 13th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Avantor has a consensus rating of “Hold” and a consensus price target of $11.83.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.